{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:27:12Z","timestamp":1793042832179,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>A severe lack of early diagnosis coupled with resistance to most available therapeutic options renders pancreatic cancer as a major clinical concern. The limited efficacy of current treatments necessitates the development of novel therapeutic strategies that are based on an understanding of the molecular mechanisms involved in pancreatic cancer progression. MicroRNAs (miRNAs) are non-coding small RNAs that regulate the expression of multiple proteins in the post-translation process and thus have promise as biomarkers, prognostic agents, and as advanced pancreatic therapies.<\/jats:p>\n                    <jats:p>Profiling of deregulated miRNAs in pancreatic cancer can\u00a0correlate to diagnosis, indicate optimal treatment and predict\u00a0response to therapy. Furthermore, understanding the main effector genes in pancreatic cancer along with downstream pathways\u00a0can identify possible miRNAs as therapeutic candidates. Additionally, obstacles to the translation of miRNAs into the clinic are\u00a0also considered.<\/jats:p>\n                    <jats:p>Distinct miRNA expression profiles can correlate to stages of malignant pancreatic disease, and hold potential as biomarkers, prognostic markers and clinical targets. However, a limited understanding and validation of the specific role of such miRNAs stunts clinical application. Target prediction using algorithms provides a wide range of possible targets, but these miRNAs still require validation through pre-clinical studies to determine the knock-on genetic effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-019-6284-y","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T07:04:07Z","timestamp":1574319847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":192,"title":["MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators"],"prefix":"10.1186","volume":"19","author":[{"given":"Afra Z.","family":"Daoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoghan J.","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1254-3745","authenticated-orcid":false,"given":"Helen O.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"6284_CR1","unstructured":"https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cancer."},{"key":"6284_CR2","unstructured":"\u201cPancreatic cancer statistics | Cancer Research UK.\u201d [Online]. Available: http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/pancreatic-cancer. [Accessed: 06-Jan-2017]."},{"issue":"6","key":"6284_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17(6):816\u201326.","journal-title":"Nat Cell Biol"},{"key":"6284_CR4","doi-asserted-by":"crossref","unstructured":"Paiella S, Sandini M, Gianotti L, Butturini G, Salvia R, Bassi C. The prognostic impact of Para-aortic lymph node metastasis in pancreatic cancer: A systematic review and meta-analysis. Eur J Surg Oncol [Internet] 2016 May;42(5):616\u2013624. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798316000974","DOI":"10.1016\/j.ejso.2016.02.003"},{"key":"6284_CR5","unstructured":"Li Z, Shang H, Zhang X, Zhang H, Bao J, Hao C. Surgical treatment for locally advanced pancreatic cancer localized in the pancreatic body and tail (report of 11 cases). Int J Clin Exp Med [Internet]. 2015;8(3):4676\u20134681. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26064401."},{"issue":"7319","key":"6284_CR6","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature09515","volume":"467","author":"S Yachida","year":"2010","unstructured":"Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467(7319):1114\u20137.","journal-title":"Nature."},{"issue":"2","key":"6284_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/bmjopen-2013-004215","volume":"4","author":"J Evans","year":"2014","unstructured":"Evans J, Chapple A, Salisbury H, Corrie P, Ziebland S. \u2018It can\u2019t be very important because it comes and goes\u2019-patients\u2019 accounts of intermittent symptoms preceding a pancreatic cancer diagnosis: A qualitative study. BMJ Open. 2014;4(2):6\u20138.","journal-title":"BMJ Open"},{"key":"6284_CR8","unstructured":"Muniraj T, Chari ST. Diabetes and pancreatic cancer. Minerva Gastroenterol Dietol [Internet]. 2012 Dec;58(4):331\u2013345. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23207610."},{"issue":"25","key":"6284_CR9","doi-asserted-by":"crossref","first-page":"38539","DOI":"10.18632\/oncotarget.9533","volume":"7","author":"L Wang","year":"2016","unstructured":"Wang L, Bai Y-Y, Yang Y, Hu F, Wang Y, Yu Z, et al. Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway. Oncotarget. 2016;7(25):38539\u201350.","journal-title":"Oncotarget."},{"issue":"7","key":"6284_CR10","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1158\/1078-0432.CCR-14-2022","volume":"21","author":"N Javeed","year":"2015","unstructured":"Javeed N, Sagar G, Dutta SK, Smyrk TC, Lau JS, Bhattacharya S, et al. Pancreatic cancer-derived exosomes cause paraneoplastic \u03b2-cell dysfunction. Clin Cancer Res. 2015;21(7):1722\u201333.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"6284_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1040-8428(03)00156-2","volume":"50","author":"F De Braud","year":"2004","unstructured":"De Braud F, Cascinu S, Gatta G. Cancer of pancreas. Crit Rev Oncol Hematol. 2004;50(2):147\u201355.","journal-title":"Crit Rev Oncol Hematol."},{"key":"6284_CR12","doi-asserted-by":"crossref","unstructured":"Jones S, Zhang X, Parsons DW, Lin JC-H, Leary RJ, Angenendt P, et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses. Science (80- ). 2008 Sep;321(5897):1801 LP \u2013 1801806.","DOI":"10.1126\/science.1164368"},{"key":"6284_CR13","unstructured":"Rozenbium E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, et al. Tumor-suppressive Pathways in Pancreatic Carcinoma. Cancer Res. 1997;57(9):1731\u20134"},{"issue":"6","key":"6284_CR14","first-page":"1547","volume":"145","author":"K Mutations","year":"1994","unstructured":"Mutations K, Ductal P. Pancreatic Ductal. 1994;145(6):1547\u20138.","journal-title":"Pancreatic Ductal"},{"issue":"4","key":"6284_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/ijms18040779","volume":"18","author":"MA Khan","year":"2017","unstructured":"Khan MA, Azim S, Zubair H, Bhardwaj A, Patel G, Khushman M, et al. Molecular drivers of Pancreatic Cancer pathogenesis: looking inward to move forward. Int J Mol Sci. 2017;18(4):779.","journal-title":"Int J Mol Sci"},{"key":"6284_CR16","first-page":"1","volume":"3","author":"A Maitra","year":"2008","unstructured":"Maitra A. H. Hruban R. Pancreatic Cancer. Cancer Res. 2008;3:1\u201330.","journal-title":"Cancer Res"},{"issue":"1","key":"6284_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0959-437X(02)00017-5","volume":"13","author":"SR Hingorani","year":"2003","unstructured":"Hingorani SR, Tuveson DA. Ras redux: rethinking how and where Ras acts. Curr Opin Genet Dev. 2003;13(1):6\u201313.","journal-title":"Curr Opin Genet Dev"},{"key":"6284_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.critrevonc.2017.01.002","volume":"111","author":"N Jonckheere","year":"2017","unstructured":"Jonckheere N, Vasseur R, Van Seuningen I. The cornerstone K-RAS mutation in pancreatic adenocarcinoma: from cell signaling network, target genes, biological processes to therapeutic targeting. Crit Rev Oncol Hematol. 2017;111:7\u201319.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"6284_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1172\/JCI59227","volume":"122","author":"Meredith A. Collins","year":"2012","unstructured":"Collins MA, Bednar F, Zhang Y, Brisset J, Galb\u00e1n S, Galb\u00e1n CJ, et al. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest. 2012;122(2):639\u201353.","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"6284_CR20","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2010","unstructured":"Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-sananikone E, et al. Oncogenic Kras maintains Pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 2010;149(3):656\u201370.","journal-title":"Cell."},{"issue":"6","key":"6284_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ccr.2009.03.022","volume":"15","author":"Anurag Singh","year":"2009","unstructured":"Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N, et al. A gene expression signature associated with \u2018K-Ras addiction\u2019 reveals regulators of EMT and tumor cell survival. Cancer Cell [Internet]. 2009 Jun 2;15(6):489\u2013500. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19477428.","journal-title":"Cancer Cell"},{"issue":"July","key":"6284_CR22","first-page":"64","volume":"297","author":"I Bernard Weinstein","year":"2002","unstructured":"Bernard Weinstein I. Addiction to oncogenes: the Achilles heal of Cancer: DISCOVER: all subjects. S CIENCE \u2019 S COMPASS. 2002;297(July):64\u20135.","journal-title":"S CIENCE \u2019 S COMPASS"},{"issue":"12","key":"6284_CR23","doi-asserted-by":"publisher","first-page":"e49707","DOI":"10.1371\/journal.pone.0049707","volume":"7","author":"Meredith A. Collins","year":"2012","unstructured":"Collins MA, Brisset J, Zhang Y, Bednar F, Pierre J, Galba S, et al. Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice. PLos One. 2012;7(12):e49707.","journal-title":"PLoS ONE"},{"issue":"26","key":"6284_CR24","doi-asserted-by":"publisher","first-page":"7996","DOI":"10.1073\/pnas.1509123112","volume":"112","author":"X Nan","year":"2015","unstructured":"Nan X, Tamg\u00fcney TM, Collisson EA, Lin L-J, Pitt C, Galeas J, et al. Ras-GTP dimers activate the mitogen-activated protein kinase (MAPK) pathway. Proc Natl Acad Sci. 2015;112(26):7996\u20138001.","journal-title":"Proc Natl Acad Sci"},{"key":"6284_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1750-2187-5-10","volume":"5","author":"Sanjit K Roy","year":"2010","unstructured":"Roy SK, Srivastava RK, Shankar S. Inhibition of PI3K \/ AKT and MAPK \/ ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal. 2010;5:10.","journal-title":"Journal of Molecular Signaling"},{"issue":"3","key":"6284_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/1097-4644(20001201)79:3<355::AID-JCB20>3.0.CO;2-0","volume":"79","author":"MJ Boucher","year":"2000","unstructured":"Boucher MJ, Morisset J, Vachon PH, Reed JC, Lain\u00e9 J, Rivard N. MEK\/ERK signaling pathway regulates the expression of Bcl-2, Bcl-XL, and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem. 2000;79(3):355\u201369.","journal-title":"J Cell Biochem"},{"issue":"2","key":"6284_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/MPA.0000000000000270","volume":"44","author":"K Taniuchi","year":"2015","unstructured":"Taniuchi K, Furihata M, Hanazaki K, Iwasaki S, Tanaka K, Shimizu T, et al. Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity. Pancreas. 2015;44(2):331\u201340.","journal-title":"Pancreas."},{"issue":"3","key":"6284_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/MPA.0b013e318238379d","volume":"41","author":"Adriana Handra-Luca","year":"2012","unstructured":"Handra-luca A, Lesty C, Hammel P, Sauvanet A, Rebours V, Martin A, et al. Biological and Prognostic Relevance of Mitogen-Activated Protein Kinases in Pancreatic Adenocarcinoma. Pancreas. 2012;41(3):416\u201321.","journal-title":"Pancreas"},{"issue":"23","key":"6284_CR29","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.1158\/1078-0432.CCR-13-2823","volume":"20","author":"Y Zhong","year":"2014","unstructured":"Zhong Y, Naito Y, Cope L, Naranjo-Suarez S, Saunders T, Hong SM, et al. Functional p38 MAPK identified by biomarker profiling of pancreatic cancer restrains growth through JNK inhibition and correlates with improved survival. Clin Cancer Res. 2014;20(23):6200\u201311.","journal-title":"Clin Cancer Res"},{"issue":"115","key":"6284_CR30","first-page":"889","volume":"59","author":"X Huang","year":"2012","unstructured":"Huang X, Wang H, Yuan Z, Huang J, Zheng Q. Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via beta-adrenergic receptor-dependent activation of P38\/MAPK pathway. Hepatogastroenterology. 2012 May;59(115):889\u201393.","journal-title":"Hepatogastroenterology."},{"issue":"2","key":"6284_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1006\/bbrc.2001.4595","volume":"282","author":"XZ Ding","year":"2001","unstructured":"Ding XZ, Adrian TE. MEK\/ERK-mediated proliferation is negatively regulated by p38 MAP kinase in the human pancreatic cancer cell line, PANC-1. Biochem Biophys Res Commun. 2001;282(2):447\u201353.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"6284_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"A Cuadrado","year":"2010","unstructured":"Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J. 2010;429(3):403\u201317.","journal-title":"Biochem J"},{"key":"6284_CR33","unstructured":"Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, et al. Abrogation of the Rb\/p16 Tumor-suppressive Pathway in Virtually All Pancreatic Carcinomas. Cancer Res. 1997;57(15):3126\u201330."},{"issue":"6","key":"6284_CR34","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/0092-8674(95)90214-7","volume":"83","author":"DE Ouelle","year":"1995","unstructured":"Ouelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 1995;83(6):993\u20131000.","journal-title":"Cell."},{"issue":"8","key":"6284_CR35","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrm3629","volume":"14","author":"C Bertoli","year":"2015","unstructured":"Bertoli C, Skotheim JM, De Bruin RAM, Street G, de Bruin RAM. Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol. 2015;14(8):518\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6810","key":"6284_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408(6810):307\u201310.","journal-title":"Nature."},{"issue":"9","key":"6284_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrc.2016.66","volume":"16","author":"A Makohon-Moore","year":"2016","unstructured":"Makohon-Moore A, Iacobuzio-Donahue CA. Pancreatic cancer biology and genetics from an evolutionary perspective. Nat Rev Cancer. 2016;16(9):553\u201365.","journal-title":"Nat Rev Cancer"},{"key":"6284_CR38","unstructured":"Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, et al. p53 Mutations in Pancreatic Carcinoma and Evidence of Common Involvement of Homocopolymer Tracts in DNA Microdeletions. Cancer Res. 1994;54(11):3025\u201333."},{"issue":"44","key":"6284_CR39","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1038\/onc.2015.25","volume":"34","author":"V Marcel","year":"2015","unstructured":"Marcel V, Catez F, Diaz JJ. P53, a translational regulator: contribution to its tumour-suppressor activity. Oncogene. 2015;34(44):5513\u201323.","journal-title":"Oncogene."},{"key":"6284_CR40","doi-asserted-by":"crossref","unstructured":"Herman JM, Crane CH, Iacobuzio-Donahue C, Abrams RA. Pancreatic Cancer. In: Clinical Radiation Oncology [Internet]. Elsevier; 2016. p. 934\u2013959.e6. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323240987000484","DOI":"10.1016\/B978-0-323-24098-7.00048-4"},{"issue":"11","key":"6284_CR41","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nrc1208","volume":"3","author":"PM Siegel","year":"2003","unstructured":"Siegel PM, Massagu\u00e9 J. Cytostatic and apoptotic actions of TGF-\u03b2 in homeostasis and cancer. Nat Rev Cancer. 2003 Nov;3(11):807\u201320.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"6284_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.tibs.2015.03.012","volume":"40","author":"Maria J. Macias","year":"2015","unstructured":"Macias MJ, Martin-malpartida P, Massague J. Structural determinants of Smad function in TGF- b signaling. Trends Biochem Sci. 2015;40(6):296\u2013308.","journal-title":"Trends in Biochemical Sciences"},{"issue":"9","key":"6284_CR43","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.tcb.2017.04.005","volume":"27","author":"EH Budi","year":"2017","unstructured":"Budi EH, Duan D, Derynck R. Transforming growth factor- b receptors and Smads : regulatory complexity and functional versatility. Trends Cell Biol. 2017;27(9):658\u201372.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"6284_CR44","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/SLA.0b013e3182827a65","volume":"258","author":"Minoru Oshima","year":"2013","unstructured":"Oshima M, Okano K, Muraki S, Haba R, Maeba T, Suzuki Y, et al. Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A\/p16, TP53, and SMAD4\/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer. Ann Surg. 2013;258(2).","journal-title":"Annals of Surgery"},{"issue":"6230","key":"6284_CR45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1126\/science.aaa1738","volume":"348","author":"J\u00f6rn M. Schmiedel","year":"2015","unstructured":"Schmiedel JM, Klemm SL, Zheng Y, Sahay A, Bl\u00fcthgen N, Marks DS, van Oudenaarden A. Gene expression. MicroRNA control of protein expression noise. Science. 2015;348(6230):128\u201332.","journal-title":"Science"},{"key":"6284_CR46","doi-asserted-by":"crossref","unstructured":"Mulholland EJ, Dunne N, McCarthy HO. MicroRNA as Therapeutic Targets for Chronic Wound Healing. Mol Ther - Nucleic Acids [Internet]. 2017 Sep 15 [cited 2018 Jan 29];8:46\u201355. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2162253117301865?via%3Dihub","DOI":"10.1016\/j.omtn.2017.06.003"},{"issue":"45","key":"6284_CR47","first-page":"1","volume":"104","author":"HK Saini","year":"2007","unstructured":"Saini HK, Griffiths-jones S. Enright AJ. Genomic analysis of human microRNA transcripts. 2007;104(45):1\u20136.","journal-title":"Genomic analysis of human microRNA transcripts"},{"key":"6284_CR48","doi-asserted-by":"crossref","unstructured":"Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? 2008;9(february).","DOI":"10.1038\/nrg2290"},{"issue":"12","key":"6284_CR49","doi-asserted-by":"publisher","first-page":"e115241","DOI":"10.1371\/journal.pone.0115241","volume":"9","author":"Christopher G. Hill","year":"2014","unstructured":"Hill CG, Jabbari N, Matyunina L V, Mcdonald JF. Functional and Evolutionary Significance of Human MicroRNA Seed Region Mutations. PLoS One. 2014;9(12):e115241.","journal-title":"PLoS ONE"},{"issue":"19","key":"6284_CR50","doi-asserted-by":"publisher","first-page":"9850","DOI":"10.1093\/nar\/gks705","volume":"40","author":"A. Dueck","year":"2012","unstructured":"Dueck A, Ziegler C, Eichner A, Berezikov E, Meister G. microRNAs associated with the different human Argonaute proteins. Nucleic Acids Res [Internet]. 2012;40(19):9850\u201362. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22844086.","journal-title":"Nucleic Acids Research"},{"issue":"9","key":"6284_CR51","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1242\/dev.002006","volume":"134","author":"V Ambros","year":"2007","unstructured":"Ambros V, Chen X. The regulation of genes and genomes by small RNAs. Development. 2007;134(9):1635\u201341.","journal-title":"Development."},{"issue":"2","key":"6284_CR52","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molcel.2004.07.007","volume":"15","author":"G Meister","year":"2004","unstructured":"Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell. 2004;15(2):185\u201397.","journal-title":"Mol Cell"},{"issue":"1","key":"6284_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","volume":"13","author":"Jian Zhang","year":"2015","unstructured":"Zhang J, Li S, Li L, Li M, Guo C, Yao J, et al. Exosome and Exosomal MicroRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics [Internet] 2015 Feb;13(1):17\u201324. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S167202291500011X","journal-title":"Genomics, Proteomics & Bioinformatics"},{"issue":"16","key":"6284_CR54","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-17-3841","volume":"78","author":"Xiaofeng Wang","year":"2018","unstructured":"Wang X, Luo G, Zhang K, Cao J, Huang C, Jiang T, et al. Hypoxic tumor-derived Exosomal miR-301a mediates M2 macrophage polarization via PTEN\/PI3K\u03b3 to promote Pancreatic Cancer metastasis. Cancer Res [Internet]. 2018;78(16):4586\u20134598. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29880482.","journal-title":"Cancer Research"},{"issue":"10","key":"6284_CR55","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/cas.12747","volume":"106","author":"Wenjing Pang","year":"2015","unstructured":"Pang W, Su J, Wang Y, Feng H, Dai X, Yuan Y, et al. Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts. Cancer Sci [Internet]. 2015 Oct;106(10):1362\u20131369. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26195069.","journal-title":"Cancer Science"},{"key":"6284_CR56","doi-asserted-by":"crossref","unstructured":"Wang M, Yu F, Ding H, Wang Y, Li P, Wang K. Emerging Function and Clinical Values of Exosomal MicroRNAs in Cancer. Mol Ther - Nucleic Acids [Internet]. 2019 Jun;16:791\u2013804. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253119301209","DOI":"10.1016\/j.omtn.2019.04.027"},{"issue":"1","key":"6284_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","volume":"302","author":"Baohong Zhang","year":"2007","unstructured":"Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol [Internet]. 2007 Feb;302(1):1\u201312. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012160606010967","journal-title":"Developmental Biology"},{"issue":"3","key":"6284_CR58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/emmm.201100209","volume":"4","author":"Marilena V. Iorio","year":"2012","unstructured":"Iorio M V, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med [Internet]. 2012 Mar;4(3):143\u2013159. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22351564.","journal-title":"EMBO Molecular Medicine"},{"issue":"7043","key":"6284_CR59","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Varez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834\u20138.","journal-title":"Nature."},{"issue":"30","key":"6284_CR60","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1038\/sj.onc.1210228","volume":"26","author":"A E Szafranska","year":"2007","unstructured":"Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplasticprocesses in pancreatic ductal adenocarcinoma. Oncogene. 2007;26(30):4442\u201352.","journal-title":"Oncogene"},{"issue":"1","key":"6284_CR61","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13148-017-0420-9","volume":"9","author":"L Moody","year":"2017","unstructured":"Moody L, He H, Pan Y-X, Chen H. Methods and novel technology for microRNA quantification in colorectal cancer screening. Clin Epigenetics. 2017;9(1):119.","journal-title":"Clin Epigenetics"},{"key":"6284_CR62","doi-asserted-by":"crossref","unstructured":"Yonemori K, Seki N, Idichi T, Kurahara H, Osako Y, Koshizuka K, et al. The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster. Oncotarget [Internet]. 2017 Sep 19;8(41):70097\u201370115. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29050264.","DOI":"10.18632\/oncotarget.19591"},{"issue":"30","key":"6284_CR63","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008 Jul;105(30):10513\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6284_CR64","doi-asserted-by":"crossref","unstructured":"Wang H, Peng R, Wang J, Qin Z, Xue L. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. Clin epigenetics [Internet]. 2018;10:59. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29713393.","DOI":"10.1186\/s13148-018-0492-1"},{"key":"6284_CR65","doi-asserted-by":"crossref","unstructured":"Rawlings-Goss RA, Campbell MC, Tishkoff SA. Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers. BMC Med Genomics [Internet]. 2014 Aug 28;7:53. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25169894.","DOI":"10.1186\/1755-8794-7-53"},{"issue":"50","key":"6284_CR66","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.1038\/sj.onc.1204935","volume":"20","author":"T Crnogorac-Jurcevic","year":"2001","unstructured":"Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E. Baron a, Terris B, et al. gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene. 2001;20(50):7437\u201346.","journal-title":"Oncogene"},{"issue":"10\u201311","key":"6284_CR67","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.clinbiochem.2013.03.019","volume":"46","author":"M Humeau","year":"2013","unstructured":"Humeau M, Torrisani J, Cordelier P. MiRNA in clinical practice: Pancreatic cancer. Clin Biochem. 2013;46(10\u201311):933\u20136.","journal-title":"Clin Biochem"},{"issue":"3","key":"6284_CR68","doi-asserted-by":"publisher","first-page":"314","DOI":"10.5114\/ceji.2018.80051","volume":"43","author":"Robert S\u0142otwi\u0144ski","year":"2018","unstructured":"S\u0142otwi\u0144ski R, Lech G, S\u0142otwi\u0144ska SM. MicroRNAs in pancreatic cancer diagnosis and therapy. Cent J Immunol [Internet]. 2018;43(3):314\u2013324. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30588176.","journal-title":"Central European Journal of Immunology"},{"issue":"2","key":"6284_CR69","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3892\/ijo.2014.2743","volume":"46","author":"MAKOTO ABUE","year":"2014","unstructured":"Abue M, Yokoyama M, Shibuya R, Tamai K, Yamaguchi K, Sato I, et al. Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. Int J Oncol [Internet]. 2015;46(2):539\u201347. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25384963.","journal-title":"International Journal of Oncology"},{"issue":"6","key":"6284_CR70","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1053\/j.gastro.2005.03.035","volume":"128","author":"CJ Wray","year":"2005","unstructured":"Wray CJ, Ahmad SA, Matthews JB, Lowy AM. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology. 2005;128(6):1626\u201341.","journal-title":"Gastroenterology"},{"issue":"6","key":"6284_CR71","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4174\/astr.2014.87.6.290","volume":"87","author":"TH Hong","year":"2014","unstructured":"Hong TH, Park IY, Tanaka K, Inoue Y, Kusunoki M, Boland C. MicroRNA expression profiling of diagnostic needle aspirates from surgical pancreatic cancer specimens. Ann Surg Treat Res. 2014;87(6):290.","journal-title":"Ann Surg Treat Res."},{"issue":"2","key":"6284_CR72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s13193-011-0042-1","volume":"2","author":"Umashankar K. Ballehaninna","year":"2011","unstructured":"Ballehaninna UK, Chamberlain RS. Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review. Indian J Surg Oncol [Internet]. 2011;2(2):88\u2013100. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22693400.","journal-title":"Indian Journal of Surgical Oncology"},{"key":"6284_CR73","first-page":"15","volume":"2013","author":"JM Winter","year":"2012","unstructured":"Winter JM, Yeo CJ, Brody JR. Diagnostic , Prognostic , and Predictive Biomarkers in Pancreatic. Cancer. May 2012;2013:15\u201322.","journal-title":"Cancer"},{"issue":"19","key":"6284_CR74","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.4161\/cc.5.19.3340","volume":"5","author":"Yoshimasa Saito","year":"2006","unstructured":"Saito Y, Jones PA. Epigenetic Activation of Tumor Suppressor MicroRNAs in Human Cancer Cells. Cell Cycle. 2006;5(19):2220-2.","journal-title":"Cell Cycle"},{"issue":"3","key":"6284_CR75","doi-asserted-by":"publisher","first-page":"326","DOI":"10.7150\/ijbs.15017","volume":"12","author":"Y Li","year":"2016","unstructured":"Li Y, Sarkar FH. MicroRNA targeted therapeutic approach for pancreatic cancer. Int J Biol Sci. 2016;12(3):326\u201337.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"6284_CR76","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ijc.22394","volume":"120","author":"JL Eun","year":"2007","unstructured":"Eun JL, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2007;120(5):1046\u201354.","journal-title":"Int J Cancer"},{"issue":"4","key":"6284_CR77","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4161\/cbt.8.4.7338","volume":"8","author":"N Habbe","year":"2009","unstructured":"Habbe N, Koorstra JBM, Mendell JT, Offerhaus GJ, Ji KR, Feldmann G, et al. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther. 2009;8(4):340\u20136.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"6284_CR78","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4174\/astr.2014.87.6.290","volume":"87","author":"TH Hong","year":"2014","unstructured":"Hong TH, Park IY. MicroRNA expression profiling of diagnostic needle aspirates from surgical pancreatic cancer specimens. Ann Surg Treat Res. 2014;87(6):290\u20137.","journal-title":"Ann Surg Treat Res"},{"issue":"4","key":"6284_CR79","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s00268-008-9833-0","volume":"33","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, et al. Profiling of 95 MicroRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg. 2009;33(4):698\u2013709.","journal-title":"World J Surg"},{"issue":"2","key":"6284_CR80","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jss.2009.10.005","volume":"169","author":"ST Mees","year":"2011","unstructured":"Mees ST, Schleicher C, Mardin WA, Senninger N, Colombo-Benkmann M, Haier J. Analyzing miRNAs in ductal adenocarcinomas of the pancreas. J Surg Res. 2011;169(2):241\u20136.","journal-title":"J Surg Res"},{"key":"6284_CR81","doi-asserted-by":"crossref","unstructured":"du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M, et al. MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions. Clin Chem. 2010;56:603\u201312.","DOI":"10.1373\/clinchem.2009.137364"},{"issue":"5","key":"6284_CR82","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.surg.2011.06.017","volume":"150","author":"K Nakata","year":"2011","unstructured":"Nakata K, Ohuchida K, Mizumoto K, Kayashima T, Ikenaga N, Sakai H, et al. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery. 2011;150(5):916\u201322.","journal-title":"Surgery."},{"key":"6284_CR83","first-page":"n\/a-n\/a","volume":"31","author":"J Namkung","year":"2015","unstructured":"Namkung J, Kwon W, Choi Y, Yi SG, Han S, Kang MJ, et al. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value. J Gastroenterol Hepatol. 2015;31:n\/a-n\/a.","journal-title":"J Gastroenterol Hepatol"},{"key":"6284_CR84","unstructured":"Wu P, Taubert H. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer. 2009."},{"issue":"11","key":"6284_CR85","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1158\/0008-5472.CAN-09-4467","volume":"70","author":"Elisa Giovannetti","year":"2010","unstructured":"Giovannetti E, Funel N, Peters GJ, Del Chiaro M, Erozenci LA, Vasile E, et al. MicroRNA-21 in Pancreatic Cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res [Internet] 2010;70(11):4528\u20134538. Available from: http:\/\/cancerres.aacrjournals.org\/lookup\/doi\/10.1158\/0008-5472.CAN-09-4467","journal-title":"Cancer Research"},{"issue":"15","key":"6284_CR86","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","volume":"27","author":"I A Asangani","year":"2007","unstructured":"Asangani IA, Rasheed SAK, Nikolova DA, Leupold JH, Colburn NH, Post S, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene [Internet]. 2008;27(15):2128\u201336. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17968323.","journal-title":"Oncogene"},{"key":"6284_CR87","doi-asserted-by":"crossref","unstructured":"Guo S, Fesler A, Wang H, Ju J. microRNA based prognostic biomarkers in pancreatic Cancer. Biomark Res [Internet]. 2018;6(1):18. Available from: https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-018-0131-1","DOI":"10.1186\/s40364-018-0131-1"},{"issue":"17","key":"6284_CR88","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.297.17.1901","volume":"297","author":"M Bloomston","year":"2007","unstructured":"Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. Jama. 2007;297(17):1901\u20138.","journal-title":"Jama."},{"issue":"2","key":"6284_CR89","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/bjc.2013.320","volume":"109","author":"Y Iwagami","year":"2013","unstructured":"Iwagami Y, Eguchi H, Nagano H, Akita H, Hama N, Wada H, et al. miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1. Br J Cancer. 2013;109(2):502\u201311.","journal-title":"Br J Cancer"},{"issue":"1","key":"6284_CR90","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1476-4598-9-169","volume":"9","author":"Jun Yu","year":"2010","unstructured":"Yu J, Ohuchida K, Mizumoto K, Sato N, Kayashima T, Fujita H, et al. MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer. 2010;28;9:169.","journal-title":"Molecular Cancer"},{"issue":"16","key":"6284_CR91","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","volume":"69","author":"Y Li","year":"2009","unstructured":"Li Y, VandenBoom TG, Kong D, Wang Z, Ali S, Philip PA, et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009 Aug;69(16):6704\u201312.","journal-title":"Cancer Res"},{"issue":"12","key":"6284_CR92","doi-asserted-by":"publisher","first-page":"9395","DOI":"10.1007\/s13277-015-3679-5","volume":"36","author":"C Liang","year":"2015","unstructured":"Liang C, Wang Z, Li YY, Yu BH, Zhang F, Li HY. miR-33a suppresses the nuclear translocation of \u03b2-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells. Tumor Biol. 2015;36(12):9395\u2013403.","journal-title":"Tumor Biol"},{"issue":"Supplement C","key":"6284_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2017.05.007","volume":"402","author":"AK Chaudhary","year":"2017","unstructured":"Chaudhary AK, Mondal G, Kumar V, Kattel K, Mahato RI. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205. Cancer Lett. 2017;402(Supplement C):1\u20138.","journal-title":"Cancer Lett"},{"issue":"38","key":"6284_CR94","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1038\/onc.2013.405","volume":"33","author":"H Ouyang","year":"2013","unstructured":"Ouyang H, Gore J, Deitz S, Korc M. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-\u03b2 actions. Oncogene [Internet]. 2014;33(38):4664\u20134674. Available from: http:\/\/www.nature.com\/articles\/onc2013405","journal-title":"Oncogene"},{"issue":"17","key":"6284_CR95","doi-asserted-by":"publisher","first-page":"5812","DOI":"10.1158\/1078-0432.CCR-11-0695","volume":"17","author":"M Preis","year":"2011","unstructured":"Preis M, Gardner TB, Gordon SR, Pipas JM, Mackenzie TA, Klein EE, et al. MicroRNA-10b expression correlates with response to Neoadjuvant therapy and survival in Pancreatic Ductal adenocarcinoma. Clin Cancer Res. 2011;17(17):5812\u201321 Available from: http:\/\/clincancerres.aacrjournals.org\/cgi\/doi\/10.1158\/1078-0432.CCR-11-0695.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"6284_CR96","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4103\/2319-4170.119690","volume":"36","author":"Dimitrios Iliopoulos","year":"2013","unstructured":"Iliopoulos D, Drakaki A. MicroRNA-gene signaling pathways in pancreatic cancer. Biomed J [Internet]. 2013;36(5):200. Available from: http:\/\/biomedj.cgu.edu.tw\/pdfs\/2013\/36\/5\/images\/BiomedJ_2013_36_5_200_119690.pdf","journal-title":"Biomedical Journal"},{"issue":"6","key":"6284_CR97","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1016\/S1470-2045(12)70073-6","volume":"13","author":"Yi W Kong","year":"2012","unstructured":"Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol [Internet]. 2012;13(6):e249\u2013e258. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204512700736","journal-title":"The Lancet Oncology"},{"issue":"8","key":"6284_CR98","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1245\/s10434-011-1602-x","volume":"18","author":"K Ohuchida","year":"2011","unstructured":"Ohuchida K, Mizumoto K, Kayashima T, Fujita H, Moriyama T, Ohtsuka T, et al. MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of Pancreatic Cancer. Ann Surg Oncol. 2011;18(8):2381\u20137 Available from: http:\/\/www.springerlink.com\/index\/10.1245\/s10434-011-1602-x.","journal-title":"Ann Surg Oncol"},{"key":"6284_CR99","doi-asserted-by":"crossref","unstructured":"Khan MA, Zubair H, Srivastava SK, Singh S, Singh AP. Insights into the role of microRNAs in Pancreatic Cancer pathogenesis: potential for diagnosis, prognosis, and therapy. Adv Exp Med biol [Internet]. 2015;889:71\u201387. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26658997.","DOI":"10.1007\/978-3-319-23730-5_5"},{"key":"6284_CR100","doi-asserted-by":"crossref","unstructured":"Mikamori M, Yamada D, Eguchi H, Hasegawa S, Kishimoto T, Tomimaru Y, et al. MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in Pancreatic Ductal adenocarcinoma. Sci rep [Internet]. 2017;7:42339. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28198398.","DOI":"10.1038\/srep42339"},{"issue":"11","key":"6284_CR101","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00268-012-1705-y","volume":"36","author":"NA Schultz","year":"2012","unstructured":"Schultz NA, Andersen KK, Roslind A, Willenbrock H, W\u00f8jdemann M, Johansen JS. Prognostic MicroRNAs in Cancer tissue from patients operated for Pancreatic Cancer\u2014five MicroRNAs in a prognostic index. World J Surg. 2012;36(11):2699\u2013707 Available from: http:\/\/link.springer.com\/10.1007\/s00268-012-1705-y.","journal-title":"World J Surg"},{"issue":"10","key":"6284_CR102","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2174\/13894501113149990181","volume":"14","author":"Priya Pai","year":"2013","unstructured":"Pai P, Rachagani S, Are C, Batra SK. Prospects of miRNA-based therapy for pancreatic cancer. Curr Drug Targets [Internet]. 2013;14(10):1101\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23834151.","journal-title":"Current Drug Targets"},{"issue":"4","key":"6284_CR103","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4166\/kjg.2015.66.4.215","volume":"66","author":"Woo Hyun Paik","year":"2015","unstructured":"Paik WH, Song BJ, Kim HW, Kim HR, Hwang J-H. MicroRNA-200c as a Prognostic Biomarker for Pancreatic Cancer. Korean J Gastroenterol [Internet]. 2015;66(4):215. Available from: https:\/\/synapse.koreamed.org\/DOIx.php?id=10.4166\/kjg.2015.66.4.215","journal-title":"The Korean Journal of Gastroenterology"},{"key":"6284_CR104","doi-asserted-by":"crossref","unstructured":"Liu Y-A, Zhang Y, Zheng Z, Li K, Wu X-H, Du Q-G, et al. MicroRNA-216b reduces growth, migration and invasion of pancreatic ductal adenocarcinoma cells by directly targeting \u03c1-associated coiled-coil containing protein kinase 1. Oncol Lett [Internet]. 2018;15(5):6745\u201351. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29616134.","DOI":"10.3892\/ol.2018.8109"},{"key":"6284_CR105","doi-asserted-by":"publisher","first-page":"108703","DOI":"10.1016\/j.biopha.2019.108703","volume":"113","author":"Juanjuan Yi","year":"2019","unstructured":"Yi J, Li S, Wang C, Cao N, Qu H, Cheng C, et al. Potential applications of polyphenols on main ncRNAs regulations as novel therapeutic strategy for cancer. Biomed Pharmacother [Internet]. 2019;113:108703. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219300010","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"6284_CR106","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03432624."},{"key":"6284_CR107","doi-asserted-by":"crossref","unstructured":"Beg MS, Brenner A, Sachdev J, Ejadi S, Borad M, Kang Y-K, et al. Abstract C43: Safety, tolerability, and clinical activity of MRX34, the first-in-class liposomal miR-34 mimic, in patients with advanced solid tumors. Mol Cancer Ther [Internet]. 2015;14(12 Supplement 2):C43\u2013C43. Available from: http:\/\/mct.aacrjournals.org\/lookup\/doi\/10.1158\/1535-7163.TARG-15-C43","DOI":"10.1158\/1535-7163.TARG-15-C43"},{"key":"6284_CR108","unstructured":"https:\/\/www.drugdevelopment-technology.com\/projects\/onpattro-for-hereditary-transthyretin-mediated-amyloidosis\/."},{"key":"6284_CR109","doi-asserted-by":"crossref","unstructured":"Cole G, Ali AA, McErlean E, Mulholland EJ, Short A, McCrudden CM, et al. DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen. Acta Biomater [Internet]. 2019 Jul; Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706119304830","DOI":"10.1016\/j.actbio.2019.07.003"},{"key":"6284_CR110","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jconrel.2014.06.048","volume":"189","author":"Helen O. McCarthy","year":"2014","unstructured":"McCarthy HO, McCaffrey J, McCrudden CM, Zholobenko A, Ali AA, McBride JW, et al. Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery. J Control Release [Internet]. 2014;189:141\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24995949.","journal-title":"Journal of Controlled Release"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6284-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T09:56:47Z","timestamp":1722074207000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6284-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6284"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6284-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"27 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1130"}}